O'Keefe Stevens Advisory’s Pfizer PFE Stock Holding History

O'Keefe Stevens Advisory’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.94M	Sell	80,568 -2,611	-3%	-$68.3K	0.4%	29
2026 Q1	$2.34M	Buy	83,179 +3,932	+5%	+$105K	0.58%	26
2025 Q4	$1.97M	Sell	79,247 -13,961	-15%	-$352K	0.51%	26
2025 Q3	$2.37M	Sell	93,208 -9,096	-9%	-$225K	0.64%	25
2025 Q2	$2.48M	Buy	102,304 +4,245	+4%	+$99K	0.7%	26
2025 Q1	$2.48M	Buy	98,059 +2,181	+2%	+$57.1K	0.81%	25
2024 Q4	$2.54M	Buy	95,878 +31,010	+48%	+$841K	0.79%	26
2024 Q3	$1.88M	Buy	64,868 +12,567	+24%	+$367K	0.57%	27
2024 Q2	$1.46M	Buy	52,301 +26,724	+104%	+$736K	0.49%	28
2024 Q1	$710K	Buy	25,577 +10,143	+66%	+$281K	0.23%	30
2023 Q4	$444K	Buy	15,434 +6,516	+73%	+$197K	0.18%	34
2023 Q3	$296K	Buy	8,918 +813	+10%	+$28.8K	0.13%	35
2023 Q2	$297K	Buy	8,105 +1,184	+17%	+$46.1K	0.13%	36
2023 Q1	$282K	Buy	6,921 +846	+14%	+$36.5K	0.14%	34
2022 Q4	$311K	Hold	6,075	–	–	0.18%	33
2022 Q3	$266K	Hold	6,075	–	–	0.18%	32
2022 Q2	$319K	Hold	6,075	–	–	0.2%	32
2022 Q1	$315K	Sell	6,075 -100	-2%	-$5.19K	0.15%	32
2021 Q4	$365K	Hold	6,175	–	–	0.17%	32
2021 Q3	$266K	Hold	6,175	–	–	0.15%	36
2021 Q2	$242K	Hold	6,175	–	–	0.13%	35
2021 Q1	$222K	Hold	6,175	–	–	0.14%	34
2020 Q4	$227K	Sell	6,175 -333	-5%	-$12.2K	0.16%	37
2020 Q3	$227K	Hold	6,508	–	–	0.18%	37
2020 Q2	$202K	Buy	+6,508	New	+$221K	0.17%	36
2019 Q4	$240K	Hold	6,508	–	–	0.18%	37
2019 Q3	$222K	Hold	6,508	–	–	0.17%	39
2019 Q2	$268K	Hold	6,508	–	–	0.2%	37
2019 Q1	$262K	Hold	6,508	–	–	0.2%	35
2018 Q4	$270K	Hold	6,508	–	–	0.24%	34
2018 Q3	$272K	Hold	6,508	–	–	0.19%	35
2018 Q2	$224K	Sell	6,508 -159	-2%	-$5.43K	0.18%	36
2018 Q1	$224K	Buy	6,667 +633	+10%	+$21.8K	0.2%	43
2017 Q4	$207K	Buy	+6,034	New	+$206K	0.19%	42

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

O'Keefe Stevens Advisory's PFE Position: Q2 2026 in Review

O'Keefe Stevens Advisory reduced its Pfizer (PFE) stake by 3.1% in Q2 2026, selling an estimated $68.3K and leaving 80,568 shares worth $1.94M. The position accounts for 0.4% of the portfolio, ranked #29.

O'Keefe Stevens Advisory first reported a position in PFE in Q4 2017 and has held it in 34 quarters since. The position peaked at $2.54M in Q4 2024. 1,247 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

O'Keefe Stevens Advisory held 80,568 shares of Pfizer worth $1.94M as of Q2 2026.
O'Keefe Stevens Advisory sold 2,611 Pfizer shares in Q2 2026, an estimated $68.3K.
Pfizer made up 0.4% of O'Keefe Stevens Advisory's portfolio in Q2 2026, its #29 holding.
O'Keefe Stevens Advisory first reported a position in Pfizer in Q4 2017 and has held it in 34 quarters since.
O'Keefe Stevens Advisory's Pfizer position peaked at $2.54M in Q4 2024.
1,247 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on O'Keefe Stevens Advisory's 13F filing for Q2 2026, filed 13 Jul 2026.